Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BRIMONIDINE vs BROLUCIZUMAB-DBLL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BRIMONIDINE vs BROLUCIZUMAB-DBLL: Safety Overview

Metric BRIMONIDINE BROLUCIZUMAB-DBLL
Total FAERS Reports 11,830 2,802
Deaths Reported 59 198
Death Rate 0.5% 7.1%
Hospitalizations 367 170
Average Patient Age 62.4 yrs 76.6 yrs
% Female Patients 70.9% 57.3%
FDA Approval Date Apr 19, 2024 N/A
Manufacturer Somerset Therapeutics, LLC N/A
Route OPHTHALMIC N/A
Marketing Status Discontinued Prescription